Newcomer Lee Nisley (CIK 1788981) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-09). Recent activity: Buy CHRS (30,000 shares), Buy MYGN (59,701 shares), Buy MYGN (49,796 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Coherus Oncology, Inc. (CHRS) | Director | Buy | 30,000 | $0 |
| 2026-06-05 | MYRIAD GENETICS INC (MYGN) | Director | Buy | 59,701 | $0 |
| 2025-06-06 | MYRIAD GENETICS INC (MYGN) | Director | Buy | 49,796 | $0 |
Source: SEC Form 4 filings · as of 2026-06-09